Comparison 8. combined regimen mifepristone/prostaglandin: misoprostol sublingual vs pv.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 failure to achieve complete abortion	1	224	Risk Ratio (M‐H, Fixed, 95% CI)	0.29 [0.06, 1.35]
2 surgical evacuation	1	327	Risk Ratio (M‐H, Fixed, 95% CI)	0.80 [0.18, 3.53]
3 ongoing pregnancy at follow‐up	1	224	Risk Ratio (M‐H, Fixed, 95% CI)	0.14 [0.01, 2.73]
4 side effects	2		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4.1 nausea	2		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.2 vomiting	2		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.3 diarrhoea	2		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 women dissatisfied with the procedure	1	298	Risk Ratio (M‐H, Fixed, 95% CI)	2.81 [1.15, 6.87]
6 side effects	1	2490	Risk Ratio (M‐H, Fixed, 95% CI)	1.10 [1.02, 1.18]
6.1 nausea	1	830	Risk Ratio (M‐H, Fixed, 95% CI)	1.10 [1.01, 1.19]
6.2 vomiting	1	830	Risk Ratio (M‐H, Fixed, 95% CI)	1.09 [0.94, 1.27]
6.3 diarrhoea	1	830	Risk Ratio (M‐H, Fixed, 95% CI)	1.11 [0.94, 1.31]